Method of treating Crohn's disease comprising a TLR2 antagonist

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10308655
APP PUB NO 20180148455A1
SERIAL NO

15578086

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to a novel small molecule TLR2 antagonist, and particularly, to 19 novel TLR2 antagonists, a pharmaceutical composition, including the antagonists, for preventing or treating inflammatory diseases, and a TLR4 regulator.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Achek, Asma Suwon-si, KR 2 0
Choi, Sang Dun Suwon-si, KR 6 1
Durai, Prasannavenkatesh Suwon-si, KR 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 4, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 4, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00